Coronary Artery Disease
Treating patients with CVD for anxiety, depression helps lower heart-related outcomes
In patients with heart failure or coronary artery disease who also had anxiety and/or depression, treatment for their mental health condition was linked to better clinical outcomes, researchers reported.
Noninvasive CAD staging system receives FDA breakthrough device designation
Cleerly has received FDA breakthrough device designation for its coronary artery disease staging system, which was also accepted into the FDA’s Total Product Life Cycle Advisory Program Pilot, according to a company press release.
Risk for death, heart events rises when combining erectile dysfunction drugs, nitrates
Men with CAD taking nitrates for chest pain plus a PDE5 inhibitor for erectile dysfunction were at greater risk for death or major adverse CV events compared with men taking nitrates alone, Swedish registry data show.
Top in cardiology: Predictors of heart disease risk; semaglutide’s role in CVD prevention
Low levels of the cytokines interleukin-4 and interleukin-17 were associated with an increased risk for coronary artery disease, data show.
Two inflammatory markers independently predict heart disease risk
Among adults presenting with chest pain, those with CAD confirmed by angiography had significantly lower levels of the cytokines interleukin-4 and interleukin-17 compared with those without CAD, data show.
Ability to detect CAD confirmed for PET with novel radiotracer
Confirming a previous report, PET with a novel radiotracer had good sensitivity and specificity for CAD detection and outperformed single-photon emission CT myocardial perfusion imaging.
PET scan-guided program superior to standard care in patients with suspected CAD
A comprehensive strategy involving shared cardiac PET scans was associated with better CV outcomes compared with standard care in patients with suspected CAD, according to the results of the CENTURY trial.
AHA announces late-breaker lineup to be presented at 2023 Scientific Sessions
The American Heart Association Scientific Sessions, which will be held live in Philadelphia and can be attended virtually Nov. 10 to 13, will feature eight late-breaking science sessions over 3 days.
FIRE: Complete revascularization benefits older patients with MI, multivessel disease
In patients aged 75 years or older with MI and multivessel CAD, physiology-guided complete revascularization improved outcomes compared with treating the culprit lesion only, according to the results of the FIRE trial.
CMS-approved criteria for cardiac imaging may cause confusion among clinicians
Appropriate use criteria that have been certified by CMS for coronary artery disease imaging are heterogeneous and, at times, discrepant, according to a review recently published in Annals of Internal Medicine.